Go back to the public home page
Hello .
 U.S. 


  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

related announcements

News

  • JPMorgan Exchange Traded Fund Trust

    Prospectus by Investment Company (Form 497)

  • Kohl's Corporation

    Kohl's Concludes Strategic Review Process - Form 8-K

  • New Residential Investment Corp.

    Statement of Changes in Beneficial Ownership (Form 4)

More

Healthcare

  • BioCryst Pharmaceuticals Inc.

    BioCryst Presents New Data Demonstrating Consistently Low Attack Rates[...]

  • Brown & Brown Inc.

    Brown & Brown, Inc., completes the acquisition of Patrick Quinlan[...]

  • Viatris Inc.

    Viatris Inc. to Release Second Quarter 2022 Financial Results on August[...]

More

Regeneron Pharmaceuticals Inc.

05/21/2022 | Press release | Distributed by Public on 05/21/2022 05:30

Evkeeza® (evinacumab) Phase 3 Trial Demonstrates 48% LDL-C Reduction in Children with Ultra-rare Form of High Cholesterol

Read this content
The text version of this document is not available. You can access the original document here.

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website.

Close

Smartlinks | Regeneron Pharmaceuticals Inc. | News | Health | Science | Research | Local News | Company News | Top Company News | Business Announcement | Products and Services | Corporate Litigation and Regulation | Pharmaceuticals | Public Companies | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Wiener Börse (ATX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | Börse Hamburg | Börse Hannover | Nasdaq Global Select Market | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Bolsa Institucional de Valores (BIVA)

 Back

Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact